What’s New in Continuous Glucose Monitoring? | Recording-What’s New in Continuous Glucose Monitoring?

Video Transcription

Video Summary

In this informative session, Dr. Viral Shah and panelists Dr. Laya Ekhlaspour and Dr. Andrew Welsh discuss revolutionary updates in continuous glucose monitoring (CGM) technology. The webinar highlights significant advancements, such as the Eversense 365 by Senseonics, a newly approved one-year-long CGM implant noted for its accuracy and minimal compression lows, providing consistent glucose readings without frequent sensor changes. Dr. Shah and colleagues also discussed updates from Abbott and Medtronic in the CGM space. Abbott's Libre 2 and 3 models now support use during medical imaging, and new versions offer interoperability with various insulin pumps. Medtronic's Simplera CGM and Guardian models continue advancing, with Simplera being trialed in different clinical settings.<br /><br />A significant update from Dexcom is its integration with electronic health records (EHR), specifically through Epic, promising a streamlined data flow between patient glucose readings and provider records, although it requires institutional setup.<br /><br />Dr. Welsh introduces over-the-counter (OTC) glucose biosensors like Dexcom Stelo and Abbott Lingo, which aim to make glucose monitoring accessible to non-diabetics and pre-diabetics for lifestyle adjustments. While these provide valuable insights into glucose management, they also pose questions about frequency of use and potential informational burden.<br /><br />The discussion underscores the varying applications, costs, and insurance implications of these technologies, emphasizing the dynamic nature of diabetes management tools. The session also covers broader implications for patient care, stressing the need for ongoing research and adaptation to these evolving technologies.

Keywords

continuous glucose monitoring

Eversense 365

Abbott Libre

Medtronic Simplera

Dexcom EHR integration

glucose biosensors

diabetes management

sensor technology

patient care

insurance implications